Relevant bibliographies by topics / Gastro-resistant tablets / Journal articles
To see the other types of publications on this topic, follow the link: Gastro-resistant tablets.

Journal articles on the topic 'Gastro-resistant tablets'

Author: Grafiati
Published: 4 June 2021
Last updated: 4 February 2022

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 20 journal articles for your research on the topic 'Gastro-resistant tablets.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Chiş, Adriana Aurelia, Isabela Crăciun, Carmen Maximiliana Dobrea, Felicia Gabriela Gligor, Angela Bărbat, and Luca Liviu Rus. "Preformulation and preliminary formulation studies of mesalazine gastro-resistant tablets." Romanian Journal of Pharmaceutical Practice 13, no. 4 (2020): 207–13. http://dx.doi.org/10.37897/rjphp.2020.4.5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Mohapatra, Sagar Kumar, Rudra Narayan Sahoo, Subrata Mallick, and Rajaram Mohapatra. "Enteric Dissolution Enhancement of Engineered Gastro Resistant Omeprazole Tablets using Hydroxypropyl Methylcellulose Acetate Succinate." Indian Journal of Pharmaceutical Education and Research 55, no. 3 (2021): 677–84. http://dx.doi.org/10.5530/ijper.55.3.139.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Villena, María José Martín, Ferderico Lara-Villoslada, María Adolfina Ruiz Martínez, and María Encarnación Morales Hernández. "Development of gastro-resistant tablets for the protection and intestinal delivery of Lactobacillus fermentum CECT 5716." International Journal of Pharmaceutics 487, no. 1-2 (2015): 314–19. http://dx.doi.org/10.1016/j.ijpharm.2015.03.078.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Bentley, S., J. C. Davies, S. Gastine, and J. F. Standing. "EPS3.10 Clinical pharmacokinetics and dose recommendations for posaconazole gastro-resistant tablets in children with cystic fibrosis." Journal of Cystic Fibrosis 20 (2021): S37—S38. http://dx.doi.org/10.1016/s1569-1993(21)01027-4.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Andrey, Pereira Lopes, Souza Bagatela Bianca, Pereira Lopes Ivan, et al. "Production of gastro-resistant coated tablets prepared from the hydroethanolic standardized roots extract of Harpagophytum procumbens DC." African Journal of Pharmacy and Pharmacology 11, no. 38 (2017): 491–500. http://dx.doi.org/10.5897/ajpp2017.4843.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Hiligsmann, M., and J. Y. Reginster. "Cost-effectiveness of gastro-resistant risedronate tablets for the treatment of postmenopausal women with osteoporosis in France." Osteoporosis International 30, no. 3 (2019): 649–58. http://dx.doi.org/10.1007/s00198-018-04821-7.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Nesterenko, V. G., R. N. Bolgarin, B. A. Rudoy, et al. "Development of a Gastro-retentive Dosage Form of a New Promising Anti-tuberculosis Drug Macozinone." Drug development & registration 10, no. 3 (2021): 55–69. http://dx.doi.org/10.33380/2305-2066-2021-10-3-55-69.

Full text
Abstract:
Introduction. Due to increase in the frequency of detecting cases of tuberculosis caused by strains of mycobacteria with resistance not only to traditional, but also recently introduced into clinical circulation anti-tuberculosis drugs, it is urgent to search for and develop new drugs that can be effective against multidrug-resistant (MDR-TB) and extensively drug resistant (XDR-TB) strains. One of the most promising classes of such compounds are fluorine derivatives of benzothiazinones, and particularly compound PBTZ169 (INN macozinone). This antibiotic has a high specificity against mycobacte
APA, Harvard, Vancouver, ISO, and other styles
8

Nalwade, Santaji Uttam, Vangala Ranga Reddy, Dantu Durga Rao, and Nagendra kumar Morisetti. "A validated stability indicating ultra performance liquid chromatographic method for determination of impurities in Esomeprazole magnesium gastro resistant tablets." Journal of Pharmaceutical and Biomedical Analysis 57 (January 2012): 109–14. http://dx.doi.org/10.1016/j.jpba.2011.08.025.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Hiligsmann, M., and J. Reginster. "PMS63 - COST-EFFECTIVENESS OF ACTONEL® 35 MG (RISEDRONATE) GASTRO-RESISTANT TABLETS FOR THE TREATMENT OF POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS IN FRANCE." Value in Health 21 (October 2018): S298. http://dx.doi.org/10.1016/j.jval.2018.09.1777.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Attila, Papp Lajos, Hancu Gabriel, Kelemen Hajnal, and Gyéresi Árpád. "Determination of enantiomeric purity of esomeprazole by capillary electrophoresis." Bulletin of Medical Sciences 93, no. 2 (2020): 93–101. http://dx.doi.org/10.2478/orvtudert-2020-0016.

Full text
Abstract:
Abstract Proton pump inhibitors are the most effective agents used in gastric hyper-acidity-related disorders. Omeprazole is a benzimidazole-derivative compound with an asymmetric sulphur in its structure, which generates its chiral character. Esomeprazole (S-omeprazole) was the first proton pump inhibitor introduced as an enantiomerically pure compound in therapy, after the successful chiral switch of the racemic omeprazole. This work is aimed at performing a complementary study to an already published chiral separation method of omeprazole. As preliminary analysis, the electrophoretic behavi
APA, Harvard, Vancouver, ISO, and other styles
11

Grau, Santiago, Carlos Solano, Carol García-Vidal, et al. "Cost Analysis of the Use of Voriconazole, Posaconazole and Micafungin in the Primary Prophylaxis of Invasive Fungal Infections in Recipients of Allogeneic Hematopoietic Stem Cell Transplants." Journal of Health Economics and Outcomes Research 3, no. 2 (2015): 153–61. http://dx.doi.org/10.36469/9832.

Full text
Abstract:
Objectives: Compare the cost of the primary prophylaxis of invasive fungal infections (IFI) with voriconazole, posaconazole, and micafungin in patients undergoing allogeneic hematopoietic stem cell transplantation (HSCT) in hospitals of the National Health System (NHS) in Spain. Methods: A cost analysis was made for 100 days and 180 days of prophylaxis and a decision tree model was developed. The efficacy rate of IFI prophylaxis and survival rate with liposomal amphotericin B treatment of prophylaxis failures were obtained from randomized trials and a meta-analysis of mixed treatment compariso
APA, Harvard, Vancouver, ISO, and other styles
12

Ozkan, Yalcin, Timurhan Ceyhan, Nuri Arslan, Yavuz Narin, and Askin Isimer. "In Vivo Gamma Scintigraphic Evaluation and Determination of a Gastro-Resistant Etodolac Tablet in Humans." Combinatorial Chemistry & High Throughput Screening 13, no. 6 (2010): 490–96. http://dx.doi.org/10.2174/138620710791515833.

Full text
APA, Harvard, Vancouver, ISO, and other styles
13

McKeage, Kate. "Posaconazole: A Review of the Gastro-Resistant Tablet and Intravenous Solution in Invasive Fungal Infections." Drugs 75, no. 4 (2015): 397–406. http://dx.doi.org/10.1007/s40265-015-0348-3.

Full text
APA, Harvard, Vancouver, ISO, and other styles
14

Govender, Mershen, Yahya Essop Choonara, Sandy van Vuuren, Pradeep Kumar, Lisa Claire du Toit, and Viness Pillay. "A gastro-resistant ovalbumin bi-layered mini-tablet-in-tablet system for the delivery of L actobacillus acidophilus probiotic to simulated human intestinal and colon conditions." Journal of Pharmacy and Pharmacology 67, no. 7 (2015): 939–50. http://dx.doi.org/10.1111/jphp.12389.

Full text
APA, Harvard, Vancouver, ISO, and other styles
15

Peterlin, Pierre, Cécile Chauvin, Steven Le Gouill, et al. "Fungal Prophylaxis with a Gastro-Resistant Posaconazole Tablet for Patients with Hematological Malignancies in the POSANANTES Study." Antimicrobial Agents and Chemotherapy 62, no. 2 (2017). http://dx.doi.org/10.1128/aac.01746-17.

Full text
Abstract:
ABSTRACT Posaconazole is an antifungal drug used in both prophylaxis and treatment of invasive fungal infections. Its oral formulation requires therapeutic drug monitoring. To overcome gastric acidity, a gastro-resistant posaconazole tablet has recently been developed. POSANANTES was a prospective noninterventional study that aimed to monitor plasma concentration trough level (C min) of posaconazole tablets used prophylactically in patients with hematological malignancies. Fifty patients were included. Group A (n = 31) included patients receiving induction chemotherapy for myeloid malignancies
APA, Harvard, Vancouver, ISO, and other styles
16

Ahad, Hindustan Abdul, Chinthaginjala Haranath, Rahul Raghav Dasari, Madana Gowthami, Naga Jyothi Varam, and Pandyala Sravanthi. "In vitro proportional investigation of different Pantoprazole sodium brands of gastro-resistant tablets." Kuwait Journal of Science 48, no. 1 (2020). http://dx.doi.org/10.48129/kjs.v48i1.8598.

Full text
Abstract:
The present work is a comparative exploration of some of the physicochemical possessions like weight change, thickness, diameter, hardness, disintegration time, in vitro drug discharge, and analysis studies of various commercially available Pantoprazole sodium tablets (PST) containing 40 mg of drug. The hardness, loss on friability, dissolution test, disintegration test, and uniformity of drug content were evaluated. All the brands meet the requirements as per the pharmacopoeial standards. The dissolution profile study revealed that PST-1 was faster, while PST-2 was slower. The dissolution inf
APA, Harvard, Vancouver, ISO, and other styles
17

Shravani, Yarra, Abdul Ahad Hindustan, Haranath Chinthaginjala, Mohamed Musa Gamaa Birir, Omer Adam Adam Ali, and Reddy Kethari Rushiketh. "Comparative in vitro drug release examination of dissimilar brands of Rabeprazole sodium Gastro-Resistant Tablets." International Journal of pharma and Bio Sciences 10, no. 5 (2020). http://dx.doi.org/10.22376/ijpbs/lpr.2020.10.5.p1-5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
18

Yan, Lufeng, Mengshan Zhu, Danli Wang, et al. "Oral Administration of Fucosylated Chondroitin Sulfate Oligomers in Gastro-Resistant Microcapsules Exhibits a Safe Antithrombotic Activity." Thrombosis and Haemostasis, August 30, 2020. http://dx.doi.org/10.1055/s-0040-1714738.

Full text
Abstract:
AbstractFucosylated chondroitin sulfate (FCS) polysaccharide isolated from sea cucumber has potent anticoagulant activity. Based on its resistance to the enzymes present in vertebrates, it may serve as an anticoagulant and shows antithrombotic effects when delivered through gastro-resistant (GR) tablets. However, due to the multiple plasma targets of FCS polysaccharide in the coagulation pathway, bleeding can occur after its oral administration. In the current study, we used FCS oligomers, in particular a mixture of oligosaccharides having 6 to 18 saccharide units, as the active ingredient in
APA, Harvard, Vancouver, ISO, and other styles
19

Petitcollin, A., C. Boglione-Kerrien, C. Tron, et al. "Population Pharmacokinetics of Posaconazole Tablets and Monte Carlo Simulations To Determine whether All Patients Should Receive the Same Dose." Antimicrobial Agents and Chemotherapy 61, no. 11 (2017). http://dx.doi.org/10.1128/aac.01166-17.

Full text
Abstract:
ABSTRACT Posaconazole is extensively used for prophylaxis for invasive fungal infections. The gastro-resistant tablet formulation has allowed the bioavailability issues encountered with the oral suspension to be overcome. However, overexposure is now frequent. This study aimed to (i) describe the pharmacokinetics of posaconazole tablets in a real-life cohort of patients with hematological malignancies and (ii) perform Monte Carlo simulations to assess the possibility that the daily dose can be reduced while keeping a sufficient exposure. Forty-nine consecutive inpatients were prospectively inc
APA, Harvard, Vancouver, ISO, and other styles
20

Ogawa, Tetsuya, Yumi Hosoda, Ai Horimoto, Yoko Nishizawa, KIYOTSUGU OMAE, and Nobuo Nagano. "SO055PROBIOTIC BIO-THREE DECREASES SERUM PHOSPHATE LEVELS WITH INVOLVEMENT OF BACTERIA IN GUT MICROBIOMA IN HEMODIALYSIS PATIENTS: A PROSPECTIVE, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTOLLED STUDY." Nephrology Dialysis Transplantation 35, Supplement_3 (2020). http://dx.doi.org/10.1093/ndt/gfaa139.so055.

Full text
Abstract:
Abstract Background and Aims Recent studies revealed that the importance of the gut microbioma in the development and progression of CKD. Dysbiosis of the intestinal microbiota increases uremic toxin, which damage the epithelial tight junctions and increase the permeability of the intestinal wall via endotoxemia and systemic inflammation. Some articles reported that probiotics reduced the uremic toxin and decreased inflammation biomarkers in CKD patients, while others reported no remarkable changes. Meanwhile, we have already reported that oral administration of Bifidobacterium longum in a gas
APA, Harvard, Vancouver, ISO, and other styles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography